期刊文献+

尿微量蛋白联合血凝在冠心病诊断中的检测价值 被引量:6

The Detection Value of Urine Microalbumin and Fibrinogen in Coronary Heart Disease
原文传递
导出
摘要 目的:探讨尿微量蛋白联合血清纤维蛋白原在冠心病的诊断价值。方法:选取同期在我院治疗的24例稳定型心绞痛的患者,36例诊断为不稳定型心绞痛的患者和30例诊断为急性心肌梗死的患者,并选择同期30例来我院体检健康志愿者为对照组。分析以上4组患者发病时尿微量蛋白及血清纤维蛋白原的变化情况。结果:与对照组比,3个冠心病组的尿微量蛋白及血清纤维蛋白原的含量显著升高(P<0.05),与稳定型心绞痛组比,不稳定型心绞痛组的尿微量蛋白及血清纤维蛋白原的含量显著升高(P<0.05);与不稳定型心绞痛组比,急性心梗的尿微量蛋白及血清纤维蛋白原的含量显著升高(P<0.05)。3组病患的尿微量蛋白及血清纤维蛋白原之间呈正相关关系(r=0.852,P<0.05)。结论:心肌梗死和心绞痛患者尿微量蛋白及血清纤维蛋白原含量较健康成人含量高,提示尿微量蛋白及血清纤维蛋白原的含量有助于对心肌梗死和心绞痛的诊断,对急性心肌梗死的诊断价值较高。 Objective: To explore the detection value of urine microalbumin and serum fibrinogen in coronary heart disease. Methods: we chose 30 acute myocardial infarction patients as a group, 36 unstable angina patients at the same period in our hospital as a group, and 24 stable angina patients as a group, 30 healthy volunteers as control group. Analyze the changes about urine microalbumin and serum fibrinogen in 4 group patients. Results: The urine microalbumin and serum fibrinogen were higher in 3 coronary heart disease groups(P〈 0.05). Compared with stable angina group, urine microalbumin and serum fibrinogen were higher in unstable angina group (P 〈0.05). Compared with unstable angina group, urine microalbumin and serum fibrinogen were higher in acute myocardial infarction group (P〈 0.05). Conclusions: Urine microalbumin and serum fibrinogen in coronary artery disease patients were higher than in healthy adults. This study suggests that there may be a relationship between levels of urine microalbumin and serum fib- rinogen with the development of coronary heart disease.
出处 《现代生物医学进展》 CAS 2012年第21期4087-4089,共3页 Progress in Modern Biomedicine
关键词 尿微量蛋白 纤维蛋白原 冠心病 Urine Microalbumin Fibrinogen Coronary Heart Disease
  • 相关文献

参考文献8

二级参考文献47

  • 1刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2620
  • 2吴华,颜红兵.关注慢性肾脏病合并冠心病患者的冠状动脉介入治疗问题——如何判断慢性肾脏病合并冠心病患者是否需要行冠脉介入治疗[J].中华医学信息导报,2005,20(2):12-13. 被引量:1
  • 3吴光哲,张必利,郑兴,秦永文.慢性肾脏病与冠心病相关性的临床研究[J].心血管康复医学杂志,2006,15(5):447-450. 被引量:17
  • 4[1]Vischetti M,Zito F,Maria Benedetta Donati,el al.Analysis of gene environment interaction in coronary heart disease:fibrinogen polymor-phisms as an example.Ital Heart J,2002,3:18223.
  • 5[3]Kant JA,Fornace AJ,Saxe D,et al.Evolu-tion and organlza-tion of the fibrinogen lo-cus on chromosome 4:gene duplication accom-panied by transposition and inversion.Proc Natl Acad Sci USA,1985,82:2344-2348
  • 6[4]Fichtlscherer S,Heeschen C,Zeiher AM.Inflammatory markers and corona-ry artery disease(review).Curr opin Pharmacol,2004.4:124-131.
  • 7[5]Lowe GD,Rumley A,Mackie IJ.Plasma fibrinogen.Ann CI in Biochem,2004,41:430-440.
  • 8[6]Behague I,Poifier O,Nicaud V,et al.fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patient with myocardial infarction the ECTIM study.Circulation,1996,93:440-449.
  • 9[7]Danesh J,Lewington s,Thompson SG,et al.Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality:an individual participant meta -analysis.JAMA,2005,294:1799-1809.
  • 10Segura J,Ruilope LM,Rodicio JL.Microalbuminuria.Clin Exp Hypertens,2004,26:701-707.

共引文献58

同被引文献51

引证文献6

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部